Pyroflam

1 x 50 ml

INJEKTIONSVÄTSKA

Active substance

Flunixin (Flunixin meglumine) : 50 mg/ml

ATC code

QM01AG90 Flunixine

QM01AG Fenamates

QM01A Antiinflammatory and antirheumatic products, non-steroids (NSAIDs)

QM01 Antiinflammatory and antirheumatic products

QM Musculo-skeletal system

Species

Cattle

Horses

Pigs

Indications

In horses:

- alleviation of inflammation and pain associated with musculoskeletal disorders.

- alleviation of visceral pain associated with colic.

- adjunctive therapy in the treatment of endotoxaemia and septic shock..

In cattle:

- reduction of acute inflammation associated with respiratory disease.

- adjunctive therapy in the treatment of acute mastitis.

In pigs:

- Adjunctive therapy in the treatment of swine respiratory diseases.

Dose to be administered and administration route

For intravenous administration to cattle and horses.

HORSES:

For use in equine colic, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight. Treatment may be repeated once or twice if colic recurs.

For use in musculo-skeletal disorders, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight, once daily for up to 5 days according to clinical response.

For the treatment of endotoxaemia or septic shock associated with gastric torsion and with other conditions in which the circulation of blood to the gastrointestinal tract is compromised: 0.25 mg/kg (1 ml per 200 kg) every 6-8 hours.

CATTLE

The recommended dose rate is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.

For intramuscular injection to pigs.

PIGS	The recommended dose rate is 2 ml per 45 kg bodyweight (equivalent to 2.2 mg flunixin/kg) once by intramuscular injection, in the neck, in conjunction with appropriate antimicrobial therapy. The injection volume should be limited to a maximum of 5 ml per injection site.

An appropriate graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.

The stopper should not be punctured more than 50 times. A draw-off needle should be used to avoid excessive puncturing of the stopper.

Do not exceed the stated dose or duration of treatment.

Adverse reactions

Flunixin meglumine is a non steroidal anti-inflammatory drug (NSAID). Untoward effects include gastrointestinal irritation, ulceration, hepatic idiosyncratic reactions, and, especially in dehydrated or hypovolaemic animals, potential for renal damage.

In pigs, transient irritation may occur at the injection site, this resolves spontaneously within 14 days.